All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma
Autor: | Dimopoulos, Meletios A., Grosicki, Sebastian, Jędrzejczak, Wiesław W., Nahi, Hareth, Gruber, Astrid, Hansson, Markus, Gupta, Neeraj, Byrne, Catriona, Labotka, Richard, Teng, Zhaoyang, Yang, Huyuan, Grzasko, Norbert, Kumar, Shaji |
---|---|
Zdroj: | In European Journal of Cancer January 2019 106:89-98 |
Databáze: | ScienceDirect |
Externí odkaz: |